Agfa PACS sales boom in first quarter

Article

Agfa is experiencing strong demand for its Impax PACS components, the Ridgefield Park, NJ,company reported last week. The company's total PACS sales inits electronic imaging division exceeded $12 million in the firstquarter of 1995, according to Vishal

Agfa is experiencing strong demand for its Impax PACS components, the Ridgefield Park, NJ,company reported last week. The company's total PACS sales inits electronic imaging division exceeded $12 million in the firstquarter of 1995, according to Vishal Wanchoo, director of electronicimaging systems.

Much of the division's strong performance came from three contractssigned since Jan. 1 that are worth a total of $8 million. Agfainked a $4 million deal with Beth Israel Hospital in New YorkCity, a $2 million contract with Indiana University in Indianapolisand a multi-year deal with InterMountain Healthcare Group in SaltLake City that is worth over $2 million in its first year.

All of the contracts are for connecting multiple sites, withthe InterMountain deal linking 23 hospitals and 30 imaging centerstogether and centralizing image archiving and reading at key facilities.The contract is valued at more than $25 million over the lifeof the deal.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.